Identification and optimization of the chemical, series of chemicals or bio-molecule that will interact with the target using impartial, expert opinion about the best equipment, services and the latest techniques
Human a7 Nicotinic Acetylcholine Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6201. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch HT™ , FLIPR®
Human Cav2.1/β4/α2δ calcium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6196. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human Nav1.8/β3 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4011. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human α3/β4 Nicotinic Receptor-expressing, division-arrested cells (CHO-K1). Cat#: CT4021. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Highest capacity for solid phase extraction: LiChrolut® EN saves time and money in solid-phase extraction as less time is required for conditioning and drying. In addition, only a little solvent is required for elution of the analytes from the cartridge bed. The reduced quantity of solvent leads to a lower degree of contamination and to an increase in detection sensitivity. This improves the analysis of the relevant extracted…
Human GABAA (α5/β2/γ2) ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4119. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human GABAA (a5/b2/g2) ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4119. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human Cav2.2/b3/a2d1 ion channel-expressing, division-arrested cells (CHO-K1). Cat#: CT4159. Three vials of Cyropreserved irradiated cells, 2x10E6 cells/vial (6x10E6 cells total). Platform validation: PatchXpress®
Human GABAA (α2β2γ2) Receptor-expressing, stable replicating cell line (CHO-K1). Cat#: CT6118. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human α7+RIC-3 Nicotinic Receptor-expressing, division-arrested cells (CHO-K1). Cat#: CT4201. Cryopreserved irradiated cells, 6 million cells per vial.. Platform validation: FlexStation III
Human GABAA (a3/b2/g2) Receptor-expressing, transiently transfected cells (HEK293). Cat#: CT7022. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress®, FLIPR®
Human b2 Adrenergic Receptor-expressing GPCR (G protein-coupled receptor) stable, replicating cell line (CHO-K1). Cat#: A600. Cryopreserved cells, 6 million cells per vial
Human b2 Adrenergic Receptor-expressing GPCR (G protein-coupled receptor) division-arrested cells (CHO-K1). Cat#: A400. Cryopreserved irradiated cells, 6 million cells per vial
Human a3/β4 Nicotinic Receptor membrane preparation derived from stable, replicating cell line. (Cat#: CT3021)
Human NCX1 Na+/Ca2+ Exhanger-expressing, stable replicating cell line (HEK293). Cat#: CT6206. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: FLIPR®
Human NCX1 Na+/Ca2+ Exhanger-expressing, transiently transfected cells (HEK293). Cat#: CT7206. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: Manual Patch Clamp, FLIPR®
Human Kv11.1 potassium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6001. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , QPatch HT™
Human Kv11.1 potassium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6002. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch HT™ , IonWorks Quattro®
Human Nav1.7 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6003. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress® , IonWorks Quattro® , FLIPR®
Human Nav1.4 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6005. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch™ , IonWorks Quattro®
Human HCN4 hyperpolarization-gated ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6006. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human Nav1.5 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6007. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch™ , PatchXpress® , IonWorks Quattro®
Human Nav1.6 sodium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6008. Cryopreserved cells, 6x10E6 cells/vial. Platform validation: PatchXpress® , QPatch™ HT , IonWorks Quattro®
Human Nav1.3 sodium ion channel-expressing, stable replicating cell line (HEK293). Cat#: CT6009. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: PatchXpress®
Human Nav1.2 sodium ion channel-expressing, stable replicating cell line (CHO-K1). Cat#: CT6010. Cryopreserved cells, 3 vials: 2x10E6 cells/vial. Platform validation: QPatch™ , IonWorks Quattro®
